Ultrabiotic (60)

$33.00

Comprehensive Probiotic Formula
Improves Digestive Health & Immune Support

  Consultar
SKU: 1570 Categoría:

Descripción

Containing fifty percent more bacteria than the label claim for maximum potency, Ultrabiotic actively works to restore the healthy bacteria lining in your gut. Maintaining healthy gut bacteria is essential for increased immune function, proper nutrient absorption and optimal digestion. All bacteria strains found in Ultrabiotic are harvested and freeze dried during their most active growth stage, ensuring they remain active and resilient. Many mainstream probiotics focus only on the number of bacteria in the capsule, while Aceva’s Ultrabiotic focuses on bacteria quality, age, and strain research for optimal results. Take 1 capsule per day or as directed by your healthcare professional.

Suplemental Facts

Suggested Use

Suggested Use:

As a dietary supplement, take one (1) capsule one time per day or as directed by your healthcare professional.

Caution:

As with any dietary supplement, consult your healthcare practitioner before using this product, especially if you are pregnant, nursing, anticipate surgery, take any medication or are otherwise under medical supervision.

Formulated To Be Free of Allergens Derived From:

Wheat, soy, eggs, fish, crustacean shellfish, tree nuts, peanuts, artificial preservatives, sweeteners, color and flavors.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Research

References and Research Abstracts Supporting Ultrabiotic

1. D. Zabolotny, L. Shynkarenko, O. Melnikov, L. Volosevich, І. Zarytska, О. Goloborodko, G. Karpenko, О. Bolyska, D. Zabolotna. Application of the probiotic medication “Acidolor” (L.rhamnosus LB3) in patients with chronic tonsillitis and evaluation of its efficacy; Journal of ear, nose and throat diseases, No5, 2003, page.2-9

2. D. Zabolotny, L. Volosevich, І. Zarytskа, V.D. Zabolotna. Perspectives of biotherapy in ENT diseases; Journal of ear, nose and throat diseases, No3-с, 2003, p.180-181

3. O. Volska, D. Zabolotna. Study of the mechanisms of antagonistic activity of the Probiotics drugs. Journal of ear, nose and throat diseases, No3-с, 2003, p.164-165

4. L. Shynkarenko, N. Dehtyrenko. Research of the Chemotherapy drugs influence on Lactic Acid Bacteria cells. Scientific news of the NTU “KPI”, 2004, 1 (33), pp.135-140

5. Shynkarenko L., Dehtyrenko N. Adhesion potency of lactic acid bacteria as factor for selection of Probiotic strains. Scientific news of the NTU “KPI”, 2004, 3 (35), pp.102-106

6. Zabolotny D., Melnilkov О., Zabolotnaya D., Shynkarenko L. Probiotic modulation of the immunogenesis in the experiment. Immunology and allergy, 1, 2006., p.19-21

7. О. Melnikov, D. Zabolotnaya. Experimental investigation of the Probiotic influence on the palate tonsils cells in patients with chronic tonsillitis in vitro. The journal of ear, nose and throat diseases, 2006, 3, pp.24-27.

8. Volska, L. Shynkarenko, I. Zarytska, D. Zabolotna. Study of the possibility of the using of the Lactobacilli for treatment and prevention of the Candida infections in ENT-organs. Odessa medical Journal, 2006, 4 (96), pp.32-36

9. О. Melnikov, D. Zabolotnaya, L. Kalinovskaya, V. Simonenko. Investigation of the functional and morphochemical characteristics of the cells and tissues under the conditions of the co-cultivation with L.rhamnosus LB3. The journal of ear, nose and throat diseases, 4, 2007, 170-172.

10. Timoshok N, Shynkarenko L, Starovoytova S, Spivak N. Investigation of interferon induction activity of new Probiotic composition and strains L.delbrueckii 86, L.rhamnosus LB3 to compare with Del-Immune V and Lactobacterin (L.plantarum); 2009, IIX Congress of Ukrainian Microbiological Society, Abstracts Book, p.264

11. Starovoytova S, Timoshok N, Gorchakov V, Spivak N. Immunomodulating abilities of Lactic Acid Bacteria.2009; Microbiol.J.,V71, 3, pp.41-47

12. Report on clinical use of the probiotic cells Lactobacillus delbrueckii LE and their lysate. A.S Prylutskyy, MD, PhD, Clinical Immunology and Allergy Department, Donetsk State Medical University, 1999

13. Savtova Z.D., Shpylevaya S.I., Tarutinov V.I., Rogatskaya V.P., NMeniok T.A., Nikolsky I.S., Mosienko V.S., Shynkarenko L.M., Chekhun V.F. Immune correction by an Immunomodulator from lactobacillus delbrueckii LE in a combined therapy of breast cancer at stages II and IV. Oncology 2000; 22:211-214

14. Shpylevaya S.I., Tarutinov V.I., Mosienko V.S., Rogatskaya V.P., Ponomarev I.O., Shynkarenko L.M., Chekhun V.F. Correction of leucopenia by a new probiotic immunomodulator Lactobacillus delbrueckii product in combined treatment of breast cancer. Oncology, 2000; 2 (1-2):83-86

15. D. Zabolotny, L. Shynkarenko, О. Melnikov, L. Volosevich, І. Zarytska, О. Goloborodko, G. Karpenko, О. Bolyska, D. Zabolotna. Application of the probiotic medication “Acidolor” in patients with chronic tonsillitis and evaluation of its efficacy; Journal of ear, nose and throat diseases, No5, 2003, page.2-9

16. L. Shynkarenko, N. Dehtyrenko. Research of the Chemotherapy drugs influence on Lactic Acid Bacteria cells. Scientific news of the NTU “KPI”, 2004, 1 (33), pp.135-140

17. Volska, L. Shynkarenko, I. Zarytska, D. Zabolotna. Study of the possibility of the using of the Lactobacilli for treatment and prevention of the Candida infections in ENT-organs. Odessa medical Journal, 2006, 4 (96), pp.32-3

18. Starovoytova S., Gorchakov V. Lactic Acid Bacteria strain Selection for Effective Probiotics Compositions. 2006, Scientific News of NTU “KPI”, v5, pp.100-103

19. Starovoytova S, Timoshok N, Gorchakov V, Spivak N. Interferon induction activity of Lactic Acid Bacteria; 2007, Immunology and Allergy (Ukrainian), #4, pp. 24-27

20. Starovoytova S., Oryabinska L, Gorchakov V. Cholinesterase and protease activity of Lactic Acid Bacteria in vitro ; 2007, Environment and Health, #4 (43), pp.68-71

21. Starovoytova S, Timoshok N, Spivak N. Influence of Lactic Acid bacteria associated cultures at mice experimental meningoencephalytic herpes infection; 2008, In Abstracts of International Conference “Antibacterial and anti-viral therapy on hospital treatment”, Charkov, Ukraine, pp.316-317

22. Timoshok N, Shynkarenko L, Starovoytova S, Spivak N. Investigation of interferon induction activity of new Probiotic composition and strains L.delbrueckii 86, L.rhamnosus to compare with Del-Immune V and Lactobacterin (L.plantarum); 2009, IIX Congress of Ukrainian Microbiological Society, Abstracts Book, p.264

23. Starovoytova S, Timoshok N, Gorchakov V, Spivak N. Immunomodulating abilities of Lactic Acid Bacteria.2009; Microbiol.J., V71, #3, pp.41-47

Valoraciones

No hay valoraciones aún.

Sé el primero en valorar “Ultrabiotic (60)”

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

¡No hay más ofertas para este producto!

Consultas generales

Aún no hay consultas.